Keyhan Sayadpour Zanjani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keyhan Sayadpour Zanjani has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Hassan Radmehr
3 shared publications- Aliakbar Zeinaloo
Department of Pediatric Cardiology, Children’s Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Ehsan Aghaei Moghadam
Pediatric Cardiology, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications Ehsan Aghaei-Moghadam
Cardiology Division, Pediatric Department, Children’s Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran
2 shared publications- Elaheh Malakan Rad
Department of Pediatric Cardiology, Children’s Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Seyyedehfatemeh Ghalibafan
Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, Chicago, IL
2 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
Acquired aortic coarctation presenting with acute paraparesis following transcatheter patent ductus arteriosus device closure in an 18‑month‑old girl: a case report
Background: Transcatheter device closure is an established treatment for patent ductus arteriosus (PDA). Acquired coarctation of the aorta (CoA) is a rare but potentially serious complication of PDA device closure. We report a case of acquired CoA presenting with acute neurological manifestations after PDA device implantation. Case presentation: An 18-month-old girl underwent transcatheter closure of a small PDA using a 6/4-mm Amplatzer Duct Occluder II (ADO II). Pre-procedural angiography showed no evidence of CoA or an anterior aortic shelf. Immediately after device deployment, the left ventricular and aortic systolic pressures were both 80 mmHg, with no measurable systolic pressure gradient, and early angiography and echocardiography showed no significant aortic obstruction. Three days after discharge, the patient developed acute bilateral lower-extremity weakness and paraparesis. Brain computed tomography showed no acute intracranial abnormality, and no dedicated spinal imaging was performed. Severe anemia (hemoglobin, 6.5 g/dL) was identified, and lower-extremity weakness improved following blood transfusion. Approximately 3 months after PDA closure, echocardiography demonstrated severe aortic isthmic obstruction with a peak gradient of approximately 45 mmHg and impaired left ventricular systolic function (LVEF, 40–43%). The patient underwent urgent surgical repair, including removal of the ADO II, resection of the narrowed aortic segment, and end-to-end anastomosis. During induction of anesthesia, she developed severe bradycardia requiring approximately 2 min of cardiopulmonary resuscitation. No lower‑extremity paralysis was observed postoperatively; however, abnormal orofacial movements developed, and electroencephalography showed no epileptiform activity. At 6-month follow-up, the neurological manifestations had resolved, while left ventricular systolic function remained mildly depressed. Conclusion: Acquired CoA after PDA device closure may present with acute neurological manifestations. This case emphasizes the importance of obtaining a complete history of recent cardiac interventions when evaluating acute neurological symptoms. Careful device selection and sizing, particularly for small PDAs near the aortic isthmus, together with systematic post-procedural surveillance, may facilitate early detection of aortic obstruction and reduce the risk of severe complications.
- 17 November 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
Open AccessAcquired aortic coarctation presenting with acute paraparesis following transcatheter patent ductus arteriosus device closure in an 18‑month‑old girl: a case report
Background: Transcatheter device closure is an established treatment for patent ductus arteriosus (PDA). Acquired coarctation of the aorta (CoA) is a rare but potentially serious complication of PDA device closure. We report a case of acquired CoA presenting with acute neurological manifestations after PDA device implantation. Case presentation: An 18-month-old girl underwent transcatheter closure of a small PDA using a 6/4-mm Amplatzer Duct Occluder II (ADO II). Pre-procedural angiography showed no evidence of CoA or an anterior aortic shelf. Immediately after device deployment, the left ventricular and aortic systolic pressures were both 80 mmHg, with no measurable systolic pressure gradient, and early angiography and echocardiography showed no significant aortic obstruction. Three days after discharge, the patient developed acute bilateral lower-extremity weakness and paraparesis. Brain computed tomography showed no acute intracranial abnormality, and no dedicated spinal imaging was performed. Severe anemia (hemoglobin, 6.5 g/dL) was identified, and lower-extremity weakness improved following blood transfusion. Approximately 3 months after PDA closure, echocardiography demonstrated severe aortic isthmic obstruction with a peak gradient of approximately 45 mmHg and impaired left ventricular systolic function (LVEF, 40–43%). The patient underwent urgent surgical repair, including removal of the ADO II, resection of the narrowed aortic segment, and end-to-end anastomosis. During induction of anesthesia, she developed severe bradycardia requiring approximately 2 min of cardiopulmonary resuscitation. No lower‑extremity paralysis was observed postoperatively; however, abnormal orofacial movements developed, and electroencephalography showed no epileptiform activity. At 6-month follow-up, the neurological manifestations had resolved, while left ventricular systolic function remained mildly depressed. Conclusion: Acquired CoA after PDA device closure may present with acute neurological manifestations. This case emphasizes the importance of obtaining a complete history of recent cardiac interventions when evaluating acute neurological symptoms. Careful device selection and sizing, particularly for small PDAs near the aortic isthmus, together with systematic post-procedural surveillance, may facilitate early detection of aortic obstruction and reduce the risk of severe complications.
- Open Access
- 1 September 2026
- Published by InkVista Publishing House
- Vol. 33 (3) , 253-259
Comparison of abdominal aorta diameter in children with bicuspid aortic valve with healthy children: Short Communication
Bicuspid aortic valve (BAV) is the most common congenital cardiac anomaly, with a prevalence of approximately 0.8% in the general population and it is predominant in males. BAV may be complicated by aortic valvular stenosis or regurgitation and is also associated with aortic wall abnormalities such as dilation, coarctation, dissection, and ...
- 1 September 2026
- Published by InkVista Publishing House
- Vol. 33 (3) , 253-259
Open AccessComparison of abdominal aorta diameter in children with bicuspid aortic valve with healthy children: Short Communication
Bicuspid aortic valve (BAV) is the most common congenital cardiac anomaly, with a prevalence of approximately 0.8% in the general population and it is predominant in males. BAV may be complicated by aortic valvular stenosis or regurgitation and is also associated with aortic wall abnormalities such as dilation, coarctation, dissection, and ...
- Open Access
- 27 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Exercise tolerance test in Kawasaki patients without coronary lesions
Kawasaki disease (KD) is a systemic vasculitis of unknown origin and the leading cause of acquired heart disease in children in developed countries. If untreated, it can cause coronary artery damage in up to 25% of cases. Lifelong follow-up is essential, even for patients without obvious coronary lesions (risk level-I KD). Since some cardiac abnormalities may not be apparent at rest, stress testing offers valuable insight. This study aimed to evaluate exercise tolerance test (ETT) outcomes in children with a history of risk level-I KD compared to a control group. This case-control study included children aged 5-17 years with documented KD without coronary lesions and at least six months since disease onset. After ethics approval, participants underwent a standardized treadmill test (modified Bruce protocol). A control group of healthy children was also included; however, exact age-matched analysis was not possible due to recruitment constraints. Sixty children were divided equally into KD and control groups. The KD group had significantly lower mean age, height, weight, and BSA compared to the control group. After adjusting for these variables, most exercise indices showed no significant difference between groups, except for chronotropic incompetence which was more prevalent in the KD group. However, most differences became non-significant after adjusting for age and BMI. Children with KD generally showed normal exercise tolerance, but a reduced chronotropic response may indicate subtle residual cardiac effects. These findings suggest a potential for subtle cardiac effects and may support the consideration of stress-based evaluation in select patients; however, further larger prospective studies are needed to confirm these observations.
- 27 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessExercise tolerance test in Kawasaki patients without coronary lesions
Kawasaki disease (KD) is a systemic vasculitis of unknown origin and the leading cause of acquired heart disease in children in developed countries. If untreated, it can cause coronary artery damage in up to 25% of cases. Lifelong follow-up is essential, even for patients without obvious coronary lesions (risk level-I KD). Since some cardiac abnormalities may not be apparent at rest, stress testing offers valuable insight. This study aimed to evaluate exercise tolerance test (ETT) outcomes in children with a history of risk level-I KD compared to a control group. This case-control study included children aged 5-17 years with documented KD without coronary lesions and at least six months since disease onset. After ethics approval, participants underwent a standardized treadmill test (modified Bruce protocol). A control group of healthy children was also included; however, exact age-matched analysis was not possible due to recruitment constraints. Sixty children were divided equally into KD and control groups. The KD group had significantly lower mean age, height, weight, and BSA compared to the control group. After adjusting for these variables, most exercise indices showed no significant difference between groups, except for chronotropic incompetence which was more prevalent in the KD group. However, most differences became non-significant after adjusting for age and BMI. Children with KD generally showed normal exercise tolerance, but a reduced chronotropic response may indicate subtle residual cardiac effects. These findings suggest a potential for subtle cardiac effects and may support the consideration of stress-based evaluation in select patients; however, further larger prospective studies are needed to confirm these observations.
- Open Access
- 8 August 2024
- Published by Springer Nature in Journal of Cardiovascular Imaging
- Vol. 32 (1) , 1-14
Echocardiographic estimation of pulmonary arterial and right atrial pressures in children with congenital heart disease: a comprehensive prospective study and introduction of novel equations
Background: Pediatric pulmonary hypertension (PH) is characterized by a mean pulmonary arterial pressure exceeding 20 mmHg. There is limited research on the suitability of adult-based methods for estimating PH in pediatric populations. Using established formulas for adults, this study aimed to evaluate the correlation between echocardiographic estimates of systolic, diastolic, and mean pulmonary arterial pressures, and mean right atrial pressures in children with congenital heart disease (CHD). Methods: A prospective study was conducted involving children with CHD undergoing cardiac catheterization without prior cardiac surgery. We used echocardiography to estimate pulmonary and right atrial pressures and compared these with invasively measured values. Four reliable regression equations were developed to estimate systolic, diastolic, and mean pulmonary arterial pressures, and mean right atrial pressures. Cutoff values were determined to predict the occurrence of PH. Linear regression, Bland–Altman analysis, and receiver operating characteristic curve analysis were performed to assess the accuracy of echocardiography and establish diagnostic thresholds for PH. Results: The study involved 55 children (23 with normal pulmonary arterial pressure and 32 with PH) with acyanotic CHD aged 1 to 192 months. Four equations were developed to detect high pulmonary arterial pressures, with cutoff values of 32.9 for systolic pulmonary arterial pressure, 14.95 for diastolic pulmonary arterial pressure, and 20.7 for mean pulmonary arterial pressure. The results showed high sensitivity and moderate specificity but a tendency to underestimate systolic and mean pulmonary arterial pressures at higher pressures. Conclusions: The study provides valuable insights into the use of adult-based echocardiographic formulas for estimating PH in pediatric patients with acyanotic CHD.
- 8 August 2024
- Published by Springer Nature in Journal of Cardiovascular Imaging
- Vol. 32 (1) , 1-14
Open AccessEchocardiographic estimation of pulmonary arterial and right atrial pressures in children with congenital heart disease: a comprehensive prospective study and introduction of novel equations
Background: Pediatric pulmonary hypertension (PH) is characterized by a mean pulmonary arterial pressure exceeding 20 mmHg. There is limited research on the suitability of adult-based methods for estimating PH in pediatric populations. Using established formulas for adults, this study aimed to evaluate the correlation between echocardiographic estimates of systolic, diastolic, and mean pulmonary arterial pressures, and mean right atrial pressures in children with congenital heart disease (CHD). Methods: A prospective study was conducted involving children with CHD undergoing cardiac catheterization without prior cardiac surgery. We used echocardiography to estimate pulmonary and right atrial pressures and compared these with invasively measured values. Four reliable regression equations were developed to estimate systolic, diastolic, and mean pulmonary arterial pressures, and mean right atrial pressures. Cutoff values were determined to predict the occurrence of PH. Linear regression, Bland–Altman analysis, and receiver operating characteristic curve analysis were performed to assess the accuracy of echocardiography and establish diagnostic thresholds for PH. Results: The study involved 55 children (23 with normal pulmonary arterial pressure and 32 with PH) with acyanotic CHD aged 1 to 192 months. Four equations were developed to detect high pulmonary arterial pressures, with cutoff values of 32.9 for systolic pulmonary arterial pressure, 14.95 for diastolic pulmonary arterial pressure, and 20.7 for mean pulmonary arterial pressure. The results showed high sensitivity and moderate specificity but a tendency to underestimate systolic and mean pulmonary arterial pressures at higher pressures. Conclusions: The study provides valuable insights into the use of adult-based echocardiographic formulas for estimating PH in pediatric patients with acyanotic CHD.
- Open Access
- 19 May 2024
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 76 (1) , 1-9
Left ventricular function assessment in Kawasaki disease by two-dimensional global longitudinal systolic strain with automated function imaging
Background: Kawasaki disease is an acute febrile vasculitis of childhood mainly affecting children under 4 years of age. In the acute stage of the disease, heart function decreases and gradually returns to normal after treatment. However, subendocardial involvement may persist, which cannot be assessed by M-mode echocardiography. Strain echocardiography is a recently developed technique to assess subendocardial involvement of myocardial deformation. We aimed to study the stratified strain of left ventricular function in a Kawasaki patient at least 6 months after the acute stage of the disease with special conditions for entering the study using two-dimensional speckle-tracking imaging. Between September 2020 and October 2022, 27 healthy children and 27 children with a history of Kawasaki disease more than 6 months ago were evaluated using two-dimensional global longitudinal peak systolic strain with automated function imaging technology. Results: The mean age of patients was 5.6 years. With M-mode echocardiography, ejection fraction of each group was in the normal range. Mean (± standard deviation) global longitudinal peak strain in four-chamber view of girls with Kawasaki disease was − 23.74 ± 2.77, and that in boys with Kawasaki disease was − 20.93 ± 2.06 (P value = 0.008). GLPS (global longitudinal peak strain) was compared as an overall average and as in a separate segment, which showed significant difference in two comparisons. In our study, a decrease in the function of some cardiac segments is reported. Global longitudinal peak strain in four-chamber view was significantly lower in boys. Comparing different segments, a difference in global left ventricular long-axis strain was found between the two groups. On the other hand, there was a major difference between the two groups in the basal inferolateral, basal anterolateral, and mid-inferolateral, which receives blood from Left Circumflex artery. Conclusion: Using stain echocardiography to detect continued subendocardial involvement in asymptomatic children with a history of Kawasaki disease for a better understanding of the condition, effective management and follow-up is recommended.
- 19 May 2024
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 76 (1) , 1-9
Open AccessLeft ventricular function assessment in Kawasaki disease by two-dimensional global longitudinal systolic strain with automated function imaging
Background: Kawasaki disease is an acute febrile vasculitis of childhood mainly affecting children under 4 years of age. In the acute stage of the disease, heart function decreases and gradually returns to normal after treatment. However, subendocardial involvement may persist, which cannot be assessed by M-mode echocardiography. Strain echocardiography is a recently developed technique to assess subendocardial involvement of myocardial deformation. We aimed to study the stratified strain of left ventricular function in a Kawasaki patient at least 6 months after the acute stage of the disease with special conditions for entering the study using two-dimensional speckle-tracking imaging. Between September 2020 and October 2022, 27 healthy children and 27 children with a history of Kawasaki disease more than 6 months ago were evaluated using two-dimensional global longitudinal peak systolic strain with automated function imaging technology. Results: The mean age of patients was 5.6 years. With M-mode echocardiography, ejection fraction of each group was in the normal range. Mean (± standard deviation) global longitudinal peak strain in four-chamber view of girls with Kawasaki disease was − 23.74 ± 2.77, and that in boys with Kawasaki disease was − 20.93 ± 2.06 (P value = 0.008). GLPS (global longitudinal peak strain) was compared as an overall average and as in a separate segment, which showed significant difference in two comparisons. In our study, a decrease in the function of some cardiac segments is reported. Global longitudinal peak strain in four-chamber view was significantly lower in boys. Comparing different segments, a difference in global left ventricular long-axis strain was found between the two groups. On the other hand, there was a major difference between the two groups in the basal inferolateral, basal anterolateral, and mid-inferolateral, which receives blood from Left Circumflex artery. Conclusion: Using stain echocardiography to detect continued subendocardial involvement in asymptomatic children with a history of Kawasaki disease for a better understanding of the condition, effective management and follow-up is recommended.
- Open Access
- 5 December 2023
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 33 (6)
Atrial Septal Defect Device Closure in Patients with Metabolic or Genetic Diseases
Background: The coexistence of a metabolic or genetic disease can complicate the course of an atrial septal defect device closure. Methods: The database of our hospital was searched for patients who had undergone atrial septal defect (ASD) device closure and had concurrent metabolic and genetic diseases. Out of 188 such patients, 11 were identified. Results: This cohort study included 11 patients with type 1 diabetes mellitus, insulin resistance, mitochondrial diseases, rickets, Seckel syndrome, Alagille syndrome, cystic fibrosis, Down syndrome, and Crigler-Najjar syndrome type II. The patients were followed for a median of 4 years. Two patients experienced thromboembolic events. One procedure failed as the device was embolized. Large devices with a waist circumference greater than 1.5 times the body weight were used in 3 patients. One patient died 19 days after the procedure due to multi-organ failure, which was not related to device closure. Conclusions: In patients with metabolic or genetic diseases, this procedure may be complicated by factors such as small patient size, hypercoagulation, organ failure (cardiac, renal, or hepatic), vascular abnormalities, and issues with anesthesia or transesophageal echocardiography. It is recommended that careful attention be given to the specific challenges associated with each disease. The utilization of large devices can be considered safe, particularly in patients beyond 4 years of age.
- 5 December 2023
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 33 (6)
Open AccessAtrial Septal Defect Device Closure in Patients with Metabolic or Genetic Diseases
Background: The coexistence of a metabolic or genetic disease can complicate the course of an atrial septal defect device closure. Methods: The database of our hospital was searched for patients who had undergone atrial septal defect (ASD) device closure and had concurrent metabolic and genetic diseases. Out of 188 such patients, 11 were identified. Results: This cohort study included 11 patients with type 1 diabetes mellitus, insulin resistance, mitochondrial diseases, rickets, Seckel syndrome, Alagille syndrome, cystic fibrosis, Down syndrome, and Crigler-Najjar syndrome type II. The patients were followed for a median of 4 years. Two patients experienced thromboembolic events. One procedure failed as the device was embolized. Large devices with a waist circumference greater than 1.5 times the body weight were used in 3 patients. One patient died 19 days after the procedure due to multi-organ failure, which was not related to device closure. Conclusions: In patients with metabolic or genetic diseases, this procedure may be complicated by factors such as small patient size, hypercoagulation, organ failure (cardiac, renal, or hepatic), vascular abnormalities, and issues with anesthesia or transesophageal echocardiography. It is recommended that careful attention be given to the specific challenges associated with each disease. The utilization of large devices can be considered safe, particularly in patients beyond 4 years of age.
- Open Access
- 21 November 2023
- Published by Knowledge E DMCC in The Journal of Tehran University Heart Center
- Vol. 18 (3) , 228-231
Neglected Partial Anomalous Pulmonary Venous Return during Atrial Septal Defect Device Closure
Partial anomalous pulmonary venous return (PAPVR) is a rare congenital heart malformation in which 1 or more pulmonary veins drain into the systemic venous circulation or directly into the right atrium instead of the left atrium. It may occur alongside other congenital heart defects, including atrial septal defect (ASD). All patients with newly diagnosed ASD must be evaluated thoroughly for the likelihood of PAPVR to select surgical or percutaneous procedures. Here, we describe a 10-year-old girl with PAPVR who underwent percutaneous device closure of her secundum ASD with her PAPVR neglected at 3 years of age. We had to correct the anomalous venous connection by removing the device during an intricate procedure. The typical connection of the pulmonary veins to the left atrium was reported on her postoperative echocardiography 1 day after surgery. The patient was discharged without complications, and her first follow-up visit 7 days after discharge was unremarkable. While the most accurate diagnostic tools for PAPVR are cardiovascular magnetic resonance imaging and computed tomographic angiography, a careful examination of the pulmonary veins during pulmonary angiography or transesophageal echocardiography in children helps identify PAPVR in patients with ASD.
- 21 November 2023
- Published by Knowledge E DMCC in The Journal of Tehran University Heart Center
- Vol. 18 (3) , 228-231
Open AccessNeglected Partial Anomalous Pulmonary Venous Return during Atrial Septal Defect Device Closure
Partial anomalous pulmonary venous return (PAPVR) is a rare congenital heart malformation in which 1 or more pulmonary veins drain into the systemic venous circulation or directly into the right atrium instead of the left atrium. It may occur alongside other congenital heart defects, including atrial septal defect (ASD). All patients with newly diagnosed ASD must be evaluated thoroughly for the likelihood of PAPVR to select surgical or percutaneous procedures. Here, we describe a 10-year-old girl with PAPVR who underwent percutaneous device closure of her secundum ASD with her PAPVR neglected at 3 years of age. We had to correct the anomalous venous connection by removing the device during an intricate procedure. The typical connection of the pulmonary veins to the left atrium was reported on her postoperative echocardiography 1 day after surgery. The patient was discharged without complications, and her first follow-up visit 7 days after discharge was unremarkable. While the most accurate diagnostic tools for PAPVR are cardiovascular magnetic resonance imaging and computed tomographic angiography, a careful examination of the pulmonary veins during pulmonary angiography or transesophageal echocardiography in children helps identify PAPVR in patients with ASD.
- 8 March 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 85, 292-298
Safety of Aortic Coarctation Treatment in Patients with Turner Syndrome: A Single-Country Case Series and Literature Review
- 8 March 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 85, 292-298
Safety of Aortic Coarctation Treatment in Patients with Turner Syndrome: A Single-Country Case Series and Literature Review
- Open Access
- 2 March 2021
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 31 (2)
Atrial Septal Defect Device Closure. Is Balloon Sizing Necessary?
Objectives: This study compared the success rate of atrial septal defect device closure in children with and without balloon sizing during the procedure. Methods: This four-year, combined retrospective and prospective study was performed at a single center. All participants underwent transcatheter closure under transthoracic echocardiography and the success rate was analyzed considering the effect of balloon sizing. Results: Eighty-eight patients with a mean age of 6.48 ± 3.32 years were enrolled. Balloon sizing was performedor in 39 (44%) patients. It didn’t change the success rate compared to 49 (56%) patients without balloon sizing. Likewise, age and sex had no effect on thesuccess rate. However; the failure rate was higher in patients with larger defects. Conclusions: The study demonstrated that balloon sizing did not influence the success rate of atrial septal defect device closure, and a precise measurement by echocardiography can be as successful as balloon sizing.
- 2 March 2021
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 31 (2)
Open AccessAtrial Septal Defect Device Closure. Is Balloon Sizing Necessary?
Objectives: This study compared the success rate of atrial septal defect device closure in children with and without balloon sizing during the procedure. Methods: This four-year, combined retrospective and prospective study was performed at a single center. All participants underwent transcatheter closure under transthoracic echocardiography and the success rate was analyzed considering the effect of balloon sizing. Results: Eighty-eight patients with a mean age of 6.48 ± 3.32 years were enrolled. Balloon sizing was performedor in 39 (44%) patients. It didn’t change the success rate compared to 49 (56%) patients without balloon sizing. Likewise, age and sex had no effect on thesuccess rate. However; the failure rate was higher in patients with larger defects. Conclusions: The study demonstrated that balloon sizing did not influence the success rate of atrial septal defect device closure, and a precise measurement by echocardiography can be as successful as balloon sizing.
- Open Access
- 1 January 2021
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2021 (1)
COVID‐19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran
Background . Promptly discovering and counteracting COVID‐19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID‐19 and various types of congenial heart disease among children. Patients and Methods . Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed. Results . The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness. Conclusion . Prompt treatment of patients with a combination of COVID‐19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.
- 1 January 2021
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2021 (1)
Open AccessCOVID‐19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran
Background . Promptly discovering and counteracting COVID‐19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID‐19 and various types of congenial heart disease among children. Patients and Methods . Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed. Results . The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness. Conclusion . Prompt treatment of patients with a combination of COVID‐19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.